Tag: immuno-oncology

July 29, 2015

NantKwest's Record-breaking $2.6-billion IPO Valuation

NantKwest hit the stock market on Tuesday with an initial public offering hat values the company at $2.6 billion.
July 23, 2015

Roche Pushes Ahead Late-Stage Pipeline Drugs to Stay In Front of Competition

Noticing biosimilar competition on the horizon, Roche Holding (OTCMKTS:RHHBY)(VTX:ROG) is aggressively pushing ahead with its late-stage pipeline drugs. In particular,...
July 10, 2015

Merck's Progress in Critical Growth Areas Increases Valuation

Forbes reports that it has upgraded Merck's (NYSE:MRK) valuation on the basis of its success in two key areas, Hepatitis...
July 8, 2015

Immunovaccine and PharmAthene Sign License Agreement to Develop and Commercialize an Anthrax Vaccine

Immunovaccine (TSX:IMV) and PharmAthene (NYSE MKY:PIP) have announced a worldwide license agreement to develop and commercialize aRecombinant Protective Antigen Anthrax...